Stay Connected With Us
Sep 20, 2020 PM EDT
Based on research findings, adding abemaciclib to hormonal therapy decreases the risk of recurrence of cancer by 25 percent in patients with HR+ or high-risk early hormone receptor-positive HER2- or human epidermal growth factor receptor 2 negative o..
May 21, 2020 AM EDT
People of color are likely to contract the coronavirus, especially those living in deprived areas.
